Cellworks
PrivateLast Round
Strategic
Jan 9, 2023
Total Funding Raised
$13M
Company Overview
Cellworks is a biotechnology company that provides a biosimulation platform designed to predict therapy response for individual patients.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Medical AI, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellworks Comps
Public and private peers based on sector, stage, and business model.
Cellworks Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jan 9, 2023 | ||||
| Series B | Dec 26, 2012 |
Key People
Founding team and executive leadership
Cellworks Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agilent Ventures | Strategic |
| Sequoia Capital | Series B, Strategic |
| UnitedHealth Group | Strategic |
Cellworks Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cellworks's valuation, stock price, and market status.
